Cambridge Investment Research Advisors, Inc. Dynavax Technologies Corp Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.6 Billion
  • Q1 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 24,044 shares of DVAX stock, worth $228,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,044
Holding current value
$228,418
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025
BUY
$12.39 - $14.4 $297,905 - $346,233
24,044 New
24,044 $312,000
Q2 2024

Jul 26, 2024
SELL
$10.73 - $12.58 $11,534 - $13,523
-1,075 Reduced 8.69%
11,290 $127,000
Q4 2023

Feb 09, 2024
BUY
$13.09 - $14.98 $161,857 - $185,227
12,365 New
12,365 $173,000
Q1 2023

May 11, 2023
SELL
$9.44 - $11.88 $18,880 - $23,760
-2,000 Reduced 15.24%
11,125 $109,000
Q3 2022

Oct 17, 2022
SELL
$9.93 - $17.44 $10,277 - $18,050
-1,035 Reduced 7.31%
13,125 $137,000
Q2 2022

Jul 13, 2022
BUY
$7.45 - $12.83 $2,607 - $4,490
350 Added 2.53%
14,160 $178,000
Q1 2022

May 12, 2022
SELL
$9.75 - $14.44 $15,600 - $23,104
-1,600 Reduced 10.38%
13,810 $149,000
Q4 2021

Feb 03, 2022
SELL
$13.17 - $20.94 $18,556 - $29,504
-1,409 Reduced 8.38%
15,410 $216,000
Q3 2021

Nov 02, 2021
SELL
$9.16 - $19.83 $56,645 - $122,628
-6,184 Reduced 26.88%
16,819 $323,000
Q2 2021

Aug 10, 2021
SELL
$7.25 - $10.99 $123,250 - $186,830
-17,000 Reduced 42.5%
23,003 $226,000
Q1 2021

May 07, 2021
SELL
$4.57 - $11.18 $47,985 - $117,390
-10,500 Reduced 20.79%
40,003 $393,000
Q4 2020

Feb 04, 2021
SELL
$3.73 - $5.6 $18,452 - $27,703
-4,947 Reduced 8.92%
50,503 $224,000
Q3 2020

Oct 29, 2020
BUY
$4.32 - $11.7 $38,880 - $105,300
9,000 Added 19.38%
55,450 $239,000
Q2 2020

Jul 27, 2020
BUY
$2.94 - $9.1 $34,692 - $107,380
11,800 Added 34.05%
46,450 $412,000
Q1 2020

May 08, 2020
SELL
$2.27 - $6.2 $6,866 - $18,755
-3,025 Reduced 8.03%
34,650 $122,000
Q4 2019

Feb 04, 2020
SELL
$3.46 - $6.93 $4,152 - $8,316
-1,200 Reduced 3.09%
37,675 $215,000
Q3 2019

Nov 06, 2019
SELL
$2.69 - $4.85 $2,690 - $4,850
-1,000 Reduced 2.51%
38,875 $139,000
Q2 2019

Aug 15, 2019
SELL
$3.65 - $7.89 $10,950 - $23,670
-3,000 Reduced 7.0%
39,875 $0
Q1 2019

May 08, 2019
SELL
$7.08 - $12.09 $2,194 - $3,747
-310 Reduced 0.72%
42,875 $0
Q4 2018

Feb 05, 2019
SELL
$8.14 - $13.28 $12,210 - $19,920
-1,500 Reduced 3.36%
43,185 $395,000
Q3 2018

Nov 02, 2018
BUY
$11.85 - $16.0 $529,517 - $714,960
44,685 New
44,685 $0

Others Institutions Holding DVAX

# of Institutions
312
Shares Held
129M
Call Options Held
493K
Put Options Held
269K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.2B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email